Send mail to Author

Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis (Article)

Please indicate your contact information and select, which author you want to contact.



 
  ______     ___     ______    _    _                ___    
 /_   _//   / _ \\  |      \\ | || | ||     ___     / _ \\  
 `-| |,-   / //\ \\ |  --  // | || | ||    /   ||  / //\ \\ 
   | ||   |  ___  |||  --  \\ | \\_/ ||   | [] || |  ___  ||
   |_||   |_||  |_|||______//  \____//     \__ || |_||  |_||
   `-`'   `-`   `-` `------`    `---`       -|_|| `-`   `-` 
                                             `-`
 


Back to frontdoor view

OPUS4 Logo